The placental immune response is dysregulated developmentally vitamin D deficient rats: Relevance to autism

Journal of Steroid Biochemistry and Molecular Biology

Volumn 180, Issue , 2018, Pages 73-80

  Ali, Asad ^a   Cui, Xiaoying ^a   Alexander, Suzanne ^a   Eyles, Darryl ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Autism; DVD deficiency; IL 1 ; IL 6; Placenta; Poly(I:C); Vitamin D

Indexed keywords

CYP27B1 PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN; INTERFERON INDUCED HELICASE C DOMAIN CONTAINING PROTEIN 1; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; POLYINOSINIC POLYCYTIDYLIC ACID; PROTEIN; RETINOIC ACID INDUCIBLE PROTEIN I; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 3; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR; CYTOKINE;

ANIMAL TISSUE; ARTICLE; AUTISM; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FETUS; IMMUNE RESPONSE; IMMUNE STATUS; MALE; MATERNAL NUTRITION; NONHUMAN; PLACENTA; RAT; VITAMIN D DEFICIENCY; ANIMAL; CHEMICALLY INDUCED; COMPLICATION; DEVELOPMENTAL DISORDER; DISEASE MODEL; DRUG EFFECT; IMMUNOLOGY; METABOLISM; PATHOLOGY; PREGNANCY; SPRAGUE DAWLEY RAT;

ANIMALS; CYTOKINES; DEVELOPMENTAL DISABILITIES; DISEASE MODELS, ANIMAL; FEMALE; MALE; PLACENTA; POLY I-C; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; VITAMIN D DEFICIENCY;

EID: 85041694364     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2018.01.015     Document Type: Article

References (66)

1. de Boo, H.A., Harding, J.E., The developmental origins of adult disease (Barker) hypothesis. Aust. N. Z. J. Obstet. Gynaecol. 46 (2006), 4–14.
2. Mahon, P., Harvey, N., Crozier, S., Inskip, H., Robinson, S., Arden, N., Swaminathan, R., Cooper, C., Godfrey, K., Low maternal vitamin D status and fetal bone development: Cohort study. J. Bone Miner. Res. 25 (2010), 14–19.
3. Kesby, J.P., Cui, X., Burne, T.H.J., Eyles, D.W., Altered dopamine ontogeny in the developmentally vitamin D deficient rat and its relevance to schizophrenia. Front. Cell. Neurosci., 7, 2013, 111.
4. Eyles, D.W., Vitamin D and autism: does skin colour modify risk?. Acta Paediatr. 99 (2010), 645–647.
5. Eyles, D.W., Burne, T.H.J., McGrath, J.J., Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease. Front. Neuroendocrinol. 34 (2013), 47–64.
6. Morales, E., Julvez, J., Torrent, M., Ballester, F., Rodriguez-Bernal, C.L., Andiarena, A., Vegas, O., Castilla, A.M., Rodriguez-Dehli, C., Tardon, A., Sunyer, J., Vitamin D in pregnancy and attention deficit hyperactivity disorder-like symptoms in childhood. Epidemiology 26 (2015), 458–465.
7. Hart, P.H., Lucas, R.M., Walsh, J.P., Zosky, G.R., Whitehouse, A.J., Zhu, K., Allen, K.L., Kusel, M.M., Anderson, D., Mountain, J.A., Vitamin D in fetal development: findings from a birth cohort study. Pediatrics 135 (2015), e167–173.
8. Murthi, P., Davies-Tuck, M., Lappas, M., Singh, H., Mockler, J., Rahman, R., Lim, R., Leaw, B., Doery, J., Wallace, E.M., Ebeling, P.R., Maternal 25-hydroxyvitamin D is inversely correlated with foetal serotonin. Clin. Endocrinol. (Oxf.) 86 (2017), 401–409.
9. Vinkhuyzen, A.A., Eyles, D.W., Burne, T.H., Blanken, L.M., Kruithof, C.J., Verhulst, F., Jaddoe, V.W., Tiemeier, H., McGrath, J.J., Gestational vitamin D deficiency and autism-related traits: the Generation R Study. Mol. Psychiatry 23 (2016), 240–246.
10. Vinkhuyzen, A.A.E., Eyles, D.W., Burne, T.H.J., Blanken, L.M.E., Kruithof, C.J., Verhulst, F., White, T., Jaddoe, V.W., Tiemeier, H., McGrath, J.J., Gestational vitamin D deficiency and autism spectrum disorder. Br. J. Psychiatry Open 3 (2017), 85–90.
11. Feron, F., Burne, T.H., Brown, J., Smith, E., McGrath, J.J., Mackay-Sim, A., Eyles, D.W., Developmental vitamin D3 deficiency alters the adult rat brain. Brain Res. Bull. 65 (2005), 141–148.
12. Kaneko, I., Sabir, M.S., Dussik, C.M., Whitfield, G.K., Karrys, A., Hsieh, J.C., Haussler, M.R., Meyer, M.B., Pike, J.W., Jurutka, P.W., 1,25-Dihydroxyvitamin D regulates expression of the tryptophan hydroxylase 2 and leptin genes: implication for behavioral influences of vitamin D. FASEB J. 29 (2015), 4023–4035.
13. Eyles, D., Brown, J., Mackay-Sim, A., McGrath, J., Feron, F., Vitamin D3 and brain development. Neuroscience 118 (2003), 641–653.
14. Ko, P., Burkert, R., McGrath, J., Eyles, D., Maternal vitamin D3 deprivation and the regulation of apoptosis and cell cycle during rat brain development. Brain Res. Dev. Brain Res., 153, 2004.
15. Ali, A., Cui, X., Eyles, D., Developmental vitamin D deficiency and autism: putative pathogenic mechanisms. J. Steroid Biochem. Mol. Biol. 175 (2016), 108–118.
16. Parker-Athill, E.C., Tan, J., Maternal immune activation and autism spectrum disorder: interleukin-6 signaling as a key mechanistic pathway. Neurosignals 18 (2010), 113–128.
17. Atladottir, H.O., Thorsen, P., Ostergaard, L., Schendel, D.E., Lemcke, S., Abdallah, M., Parner, E.T., Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J. Autism Dev. Disord. 40 (2010), 1423–1430.
18. Brown, A.S., Prenatal infection as a risk factor for schizophrenia. Schizophr. Bull. 32 (2006), 200–202.
19. Kern, J.K., Geier, D.A., Sykes, L.K., Geier, M.R., Relevance of neuroinflammation and encephalitis in autism. Front. Cell. Neurosci., 9, 2015, 519.
20. Boksa, P., Effects of prenatal infection on brain development and behavior: a review of findings from animal models. Brain Behav. Immun. 24 (2010), 881–897.
21. Vuillermot, S., Luan, W., Meyer, U., Eyles, D., Vitamin D treatment during pregnancy prevents autism-related phenotypes in a mouse model of maternal immune activation. Mol. Autism, 8, 2017, 9.
22. Saad, K., Abdel-Rahman, A.A., Elserogy, Y.M., Al-Atram, A.A., El-Houfey, A.A., Othman, H.A., Bjorklund, G., Jia, F., Urbina, M.A., Abo-Elela, M.G.M., Ahmad, F.A., Abd El-Baseer, K.A., Ahmed, A.E., Abdel-Salam, A.M., Randomized controlled trial of vitamin D supplementation in children with autism spectrum disorder. J. Child Psychol. Psychiatry 59 (2018), 20–29.
23. Saad, K., Abdel-Rahman, A.A., Elserogy, Y.M., Al-Atram, A.A., Cannell, J.J., Bjorklund, G., Abdel-Reheim, M.K., Othman, H.A., El-Houfey, A.A., Abd El-Aziz, N.H., Abd El-Baseer, K.A., Ahmed, A.E., Ali, A.M., Vitamin D status in autism spectrum disorders and the efficacy of vitamin D supplementation in autistic children. Nutr. Neurosci. 19 (2016), 346–351.
24. Feng, J., Shan, L., Du, L., Wang, B., Li, H., Wang, W., Wang, T., Dong, H., Yue, X., Xu, Z., Staal, W.G., Jia, F., Clinical improvement following vitamin D3 supplementation in autism spectrum disorder. Nutr. Neurosci. 20 (2017), 284–290.
25. Aranow, C., Vitamin D and the immune system. J. Invest. Med. 59 (2011), 881–886.
26. Tamblyn, J.A., Hewison, M., Wagner, C.L., Bulmer, J.N., Kilby, M.D., Immunological role of vitamin D at the maternal-fetal interface. J. Endocrinol. 224 (2015), R107–121.
27. Murthi, P., Yong, H.E.J., Ngyuen, T.P.H., Ellery, S., Singh, H., Rahman, R., Dickinson, H., Walker, D.W., Davies-Tuck, M., Wallace, E.M., Ebeling, P.R., Role of the placental vitamin D receptor in modulating feto-placental growth in fetal growth restriction and preeclampsia-affected pregnancies. Front. Physiol., 7, 2016, 43.
28. Tessier, D.R., Raha, S., Holloway, A.C., Yockell-Lelièvre, J., Tayade, C., Gruslin, A., Characterization of immune cells and cytokine localization in the rat utero-placental unit mid- to late gestation. J. Reprod. Immunol. 110 (2015), 89–101.
29. Hsiao, E.Y., Patterson, P.H., Placental regulation of maternal-fetal interactions and brain development. Dev. Neurobiol. 72 (2012), 1317–1326.
30. Jansson, T., Powell, T.L., Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches. Clin. Sci. (Lond.) 113 (2007), 1–13.
31. Von Beckerath, A.K., Kollmann, M., Rotky-Fast, C., Karpf, E., Lang, U., Klaritsch, P., Perinatal complications and long-term neurodevelopmental outcome of infants with intrauterine growth restriction. Am. J. Obstet. Gynecol., 208, 2013 130.e131-130.e136.
32. Chen, Y.H., Yu, Z., Fu, L., Wang, H., Chen, X., Zhang, C., Lv, Z.M., Xu, D.X., Vitamin D3 inhibits lipopolysaccharide-induced placental inflammation through reinforcing interaction between vitamin D receptor and nuclear factor kappa B p65 subunit. Sci. Rep., 5, 2015, 10871.
33. Sathishkumar, K., Elkins, R., Chinnathambi, V., Gao, H., Hankins, G.D., Yallampalli, C., Prenatal testosterone-induced fetal growth restriction is associated with down-regulation of rat placental amino acid transport. Reprod. Biol. Endocrinol., 9, 2011, 110.
34. vom Saal, F.S., The intrauterine position phenomenon: effects on physiology, aggressive behavior and population dynamics in house mice. Prog. Clin. Biol. Res. 169 (1984), 135–179.
35. Gilligan, J., Tong, M., Longato, L., de la Monte, S.M., Gundogan, F., Precision-cut slice culture method for rat placenta. Placenta 33 (2012), 67–72.
36. Yoneyama, M., Kikuchi, M., Natsukawa, T., Shinobu, N., Imaizumi, T., Miyagishi, M., Taira, K., Akira, S., Fujita, T., The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5 (2004), 730–737.
37. Schmittgen, T.D., Livak, K.J., Analyzing real-time PCR data by the comparative CT method. Nat. Protoc. 3 (2008), 1101–1108.
38. Reikine, S., Nguyen, J.B., Modis, Y., Pattern recognition and signaling mechanisms of RIG-I and MDA5. Front. Immunol., 5, 2014, 342.
39. Hsiao, E.Y., Patterson, P.H., Activation of the maternal immune system induces endocrine changes in the placenta via IL-6. Brain Behav. Immun. 25 (2011), 604–615.
40. Reins, R.Y., Baidouri, H., McDermott, A.M., Vitamin D activation and function in human corneal epithelial cells during TLR-induced inflammation. Invest. Ophthalmol. Vis. Sci. 56 (2015), 7715–7727.
41. Kato, H., Sato, S., Yoneyama, M., Yamamoto, M., Uematsu, S., Matsui, K., Tsujimura, T., Takeda, K., Fujita, T., Takeuchi, O., Akira, S., Cell type-specific involvement of RIG-I in antiviral response. Immunity 23 (2005), 19–28.
42. Holm, G.H., Zurney, J., Tumilasci, V., Leveille, S., Danthi, P., Hiscott, J., Sherry, B., Dermody, T.S., Retinoic acid-inducible gene-I and interferon-beta promoter stimulator-1 augment proapoptotic responses following mammalian reovirus infection via interferon regulatory factor-3. J. Biol. Chem. 282 (2007), 21953–21961.
43. Liu, F., Wu, S., Ren, H., Gu, J., Klotho suppresses RIG-I-mediated senescence-associated inflammation. Nat. Cell Biol. 13 (2011), 254–262.
44. Poeck, H., Bscheider, M., Gross, O., Finger, K., Roth, S., Rebsamen, M., Hannesschlager, N., Schlee, M., Rothenfusser, S., Barchet, W., Kato, H., Akira, S., Inoue, S., Endres, S., Peschel, C., Hartmann, G., Hornung, V., Ruland, J., Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1 beta production. Nat. Immunol. 11 (2010), 63–69.
45. Liu, N.Q., Kaplan, A.T., Lagishetty, V., Ouyang, Y.B., Ouyang, Y., Simmons, C.F., Equils, O., Hewison, M., Vitamin D and the regulation of placental inflammation. J. Immunol. (Baltim. Md.: 1950) 186 (2011), 5968–5974.
46. Harju, K., Glumoff, V., Hallman, M., Ontogeny of toll-like receptors Tlr2 and Tlr4 in mice. Pediatr. Res. 49 (2001), 81–83.
47. Hewison, M., Vitamin D and the immune system: new perspectives on an old theme. Endocrinol. Metab. Clin. N. Am. 39 (2010), 365–379 table of contents.
48. Goldenberg, R.L., Andrews, W.W., Faye-Petersen, O.M., Goepfert, A.R., Cliver, S.P., Hauth, J.C., The Alabama preterm birth study: intrauterine infection and placental histologic findings in preterm births of males and females less than 32 weeks. Am. J. Obstet. Gynecol. 195 (2006), 1533–1537.
49. Challis, J., Newnham, J., Petraglia, F., Yeganegi, M., Bocking, A., Fetal sex and preterm birth. Placenta 34 (2013), 95–99.
50. Olmos-Ortiz, A., García-Quiroz, J., López-Marure, R., González-Curiel, I., Rivas-Santiago, B., Olivares, A., Avila, E., Barrera, D., Halhali, A., Caldiño, F., Larrea, F., Díaz, L., Evidence of sexual dimorphism in placental vitamin D metabolism: testosterone inhibits calcitriol-dependent cathelicidin expression. J. Steroid Biochem. Mol. Biol. 163 (2016), 173–182.
51. Kin, N.W., Chen, Y., Stefanov, E.K., Gallo, R.L., Kearney, J.F., Cathelin-related antimicrobial peptide differentially regulates T- and B-cell function. Eur. J. Immunol. 41 (2011), 3006–3016.
52. Kurosaka, K., Chen, Q., Yarovinsky, F., Oppenheim, J.J., Yang, D., Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as an immune adjuvant. J. Immunol. 174 (2005), 6257–6265.
53. Lombardo, M.V., Moon, H.M., Su, J., Palmer, T.D., Courchesne, E., Pramparo, T., Maternal immune activation dysregulation of the fetal brain transcriptome and relevance to the pathophysiology of autism spectrum disorder. Mol. Psychiatry, 2017, 10.1038/mp.2017.15.
54. Smith, S.E.P., Li, J., Garbett, K., Mirnics, K., Patterson, P.H., Maternal immune activation alters fetal brain development through interleukin-6. J. Neurosci., 27, 2007.
55. Du, L., Zhao, G., Duan, Z., Li, F., Behavioral improvements in a valproic acid rat model of autism following vitamin D supplementation. Psychiatry Res. 253 (2017), 28–32.
56. Arrode-Bruses, G., Bruses, J.L., Maternal immune activation by poly I:C induces expression of cytokines IL-1beta and IL-13, chemokine MCP-1 and colony stimulating factor VEGF in fetal mouse brain. J. Neuroinflammation, 9, 2012, 83.
57. He, F., Ge, W., Martinowich, K., Becker-Catania, S., Coskun, V., Zhu, W., Wu, H., Castro, D., Guillemot, F., Fan, G., de Vellis, J., Sun, Y.E., A positive autoregulatory loop of Jak-STAT signaling controls the onset of astrogliogenesis. Nat. Neurosci. 8 (2005), 616–625.
58. Yao, J.S., Zhai, W., Young, W.L., Yang, G.Y., Interleukin-6 triggers human cerebral endothelial cells proliferation and migration: the role for KDR and MMP-9. Biochem. Biophys. Res. Commun. 342 (2006), 1396–1404.
59. Murphy, P.G., Borthwick, L.A., Altares, M., Gauldie, J., Kaplan, D., Richardson, P.M., Reciprocal actions of interleukin-6 and brain-derived neurotrophic factor on rat and mouse primary sensory neurons. Eur. J. Neurosci. 12 (2000), 1891–1899.
60. Lager, S., Jansson, N., Olsson, A.L., Wennergren, M., Jansson, T., Powell, T.L., Effect of IL-6 and TNF-alpha on fatty acid uptake in cultured human primary trophoblast cells. Placenta 32 (2011), 121–127.
61. Beall, M.H., Amidi, F., Gayle, D.A., Wang, S., Beloosesky, R., Ross, M.G., Placental and fetal membrane nephrin and Neph1 gene expression: response to inflammation. J. Soc. Gynecol. Invest. 12 (2005), 298–302.
62. Fan, J., Wojnar, M.M., Theodorakis, M., Lang, C.H., Regulation of insulin-like growth factor (IGF)-I mRNA and peptide and IGF-binding proteins by interleukin-1. Am. J. Physiol. 270 (1996), R621–R629.
63. Ajo, R., Cacicedo, L., Navarro, C., Sanchez-Franco, F., Growth hormone action on proliferation and differentiation of cerebral cortical cells from fetal rat. Endocrinology 144 (2003), 1086–1097.
64. Marx, C.E., Jarskog, L.F., Lauder, J.M., Lieberman, J.A., Gilmore, J.H., Cytokine effects on cortical neuron MAP-2 immunoreactivity: implications for schizophrenia. Biol. Psychiatry 50 (2001), 743–749.
65. Neumann, H., Schweigreiter, R., Yamashita, T., Rosenkranz, K., Wekerle, H., Barde, Y.A., Tumor necrosis factor inhibits neurite outgrowth and branching of hippocampal neurons by a rho-dependent mechanism. J. Neurosci. 22 (2002), 854–862.
66. Werling, D.M., Geschwind, D.H., Sex differences in autism spectrum disorders. Curr. Opin. Neurol. 26 (2013), 146–153.